Shu Fang

机构：Peking University, Chengdu Women's and Children's Central Hospital, He University, Shandong Tumor Hospital, Institute of Biophysics, Peking University People's Hospital, Shandong First Medical University, University of Chinese Academy of Sciences, China Jiliang University, Yangzhou University · ORCID：0009-0008-7543-5697

发表论文 124 篇 · 总被引 1947 次 · h-index 22

代表论文

• Relationship between fear of progression and symptom burden, disease factors and social/family factors in patients with stage‐IV breast cancer in Shandong, China (2024 · Cancer Medicine · 被引 12)
• Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective study (2023 · eLife · 被引 10)
• Isocyanic acid–mediated NLRP3 carbamoylation reduces NLRP3-NEK7 interaction and limits inflammasome activation (2025 · Science Advances · 被引 7)
• Ultra-sensitive boric acid detection using a plasmonic fiber-optic spectral comb and MEA modified with gold nanoparticles (2025 · Optics Letters · 被引 6)
• Efficacy and safety of pyrotinib combined with albumin‐bound paclitaxel as first‐line treatment for HER2‐positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single‐arm, phase 2 prospective clinical trial (2024 · Clinical and Translational Medicine · 被引 6)
• DPPA2/4 Promote the Pluripotency and Proliferation of Bovine Extended Pluripotent Stem Cells by Upregulating the PI3K/AKT/GSK3β/β-Catenin Signaling Pathway (2024 · Cells · 被引 5)